Holdaas, H., Mjøen, G. and Jardine, A. G. (2017) Belatacept: where the BENEFITS outweigh the risk. American Journal of Kidney Diseases, 69(5), pp. 561-563. (doi: 10.1053/j.ajkd.2017.02.007) (PMID:28434523)
|
Text
140635.pdf - Accepted Version 392kB |
Abstract
No abstract available.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Jardine, Professor Alan |
| Authors: | Holdaas, H., Mjøen, G., and Jardine, A. G. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | American Journal of Kidney Diseases |
| Publisher: | Elsevier |
| ISSN: | 0272-6386 |
| ISSN (Online): | 1523-6838 |
| Published Online: | 20 April 2017 |
| Copyright Holders: | Copyright © 2017 National Kidney Foundation, Inc. |
| First Published: | First published in American Journal of Kidney Diseases 69(5): 561-563 |
| Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details